TARRYTOWN, N.Y., Sept. 08, 2023 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that Robert E. Landry, Executive Vice President, Finance and Chief Financial Officer of Regeneron, will retire in February 2024. Christopher Fenimore, current Senior Vice President, Head of Accounting and Controller at Regeneron, will succeed Mr.…Read More
Regeneron Pharmaceuticals Inc Regeneron Provides Update on Planned Chief Financial Officer Transition
